Table of Contents
Overview
New York, NY – May 08, 2025 – Global Empty Capsules Market size is expected to be worth around USD 6.4 Billion by 2033 from USD 3.5 Billion in 2023, growing at a CAGR of 6.8% during the forecast period from 2024 to 2033. This growth is being driven by the increasing demand for dietary supplements, rising geriatric populations, and a shift towards plant-based and personalized medicine.
Empty capsules are widely used for the encapsulation of both pharmaceutical drugs and nutraceutical products. Gelatin capsules continue to dominate due to their cost-effectiveness and established usage. However, vegetarian capsules made from hydroxypropyl methylcellulose (HPMC) are gaining popularity among vegan and health-conscious consumers. These capsules offer better stability in humid conditions and are ideal for hygroscopic drugs.
The healthcare and wellness industry’s move towards clean-label and non-GMO products has further supported demand for vegetarian capsules. Additionally, increased R&D activities and capsule innovations for modified drug delivery have expanded their applications in oncology, cardiovascular, and gastroenterology segments.
Regionally, North America leads the market owing to a high rate of supplement consumption and advanced pharmaceutical infrastructure. Meanwhile, Asia-Pacific is projected to witness the fastest growth, driven by population expansion, increasing health awareness, and local pharmaceutical production.
Key Takeaways
- Market Size: The global empty capsules market was valued at approximately USD 3.5 billion in 2023 and is projected to reach around USD 6.4 billion by 2033.
- Market Growth: The market is anticipated to grow at a compound annual growth rate (CAGR) of 6.8% between 2024 and 2033.
- Product Segment Analysis: In 2023, non-gelatin capsules dominated the product segment, accounting for approximately 79% of the overall market share, indicating a strong preference for plant-based and synthetic alternatives.
- Capsule Size Preference: “Size 0” capsules emerged as the most widely adopted capsule type in 2023, securing a 23% share of the global market.
- End-Use Industry Analysis: The pharmaceutical sector represented the largest end-use segment in 2023, holding a 37% share of the market, driven by its extensive demand for encapsulated drug formulations.
- Regional Landscape: North America led the global market in 2023 with a commanding 40% share, supported by advanced manufacturing infrastructure and regulatory compliance.
- Competitive Landscape: Market leaders are characterized by robust research and development capabilities, expansive global distribution channels, and strategic growth measures such as mergers and acquisitions.
- Regulatory Framework: Regulatory oversight, particularly in North America and Europe, plays a critical role in market structure by enforcing stringent quality and safety standards. This presents both compliance challenges and opportunities for differentiation.
Segmentation Analysis
- Product Analysis: In 2023, non-gelatin capsules accounted for 79% of the global empty capsules market, reflecting strong consumer demand for plant-based alternatives. These capsules, typically made from hydroxypropyl methylcellulose (HPMC), align with vegan, vegetarian, and allergen-free preferences. The declining use of gelatin capsules is influenced by ethical and health considerations. This trend underscores a broader industry shift towards clean-label and sustainable products, driving innovation in non-gelatin capsule development across pharmaceutical and nutraceutical sectors.
- Capsule Analysis: “Size 0” capsules held a 23% share of the empty capsules market in 2023, making them the most preferred size due to their balanced fill capacity and ease of consumption. Larger capsules, such as “Size 000,” are favored for high-dose supplements, while “Size 00” remains popular in daily dietary intake. Smaller variants, from “Size 1” to “Size 5,” cater to niche therapeutic and pediatric needs. This diversity in sizing enables manufacturers to meet various dosage and consumer requirements.
- End-Use Analysis: The pharmaceutical industry dominated end-use in 2023 with a 37% market share, emphasizing its dependence on capsules for efficient drug delivery. The nutraceutical segment also saw strong growth, supported by rising demand for wellness supplements. Additionally, the cosmetics industry uses capsules to protect and deliver active ingredients in skincare formulations. Clinical Research Organizations (CROs) play a vital role by using capsules for controlled drug administration in clinical trials, aiding drug development processes and regulatory compliance.
Market Segments
By Product
- Gelatin
- Non-Gelatin Capsules
By Capsule Size
- Size “000” Empty Capsules
- Size “00” Empty Capsules
- Size “0” Empty Capsules
- Size “1” Empty Capsules
- Size “2” Empty Capsules
- Size “3” Empty Capsules
- Size “4” Empty Capsules
- Size “5” Empty Capsules
By End-user
- Pharmaceutical Industy
- Nutraceutical and Cosmetics Industries
- Clinical Research Organizations
Regional Analysis
In 2023, North America held a leading position in the global empty capsules market, capturing approximately 40% of the total market share. This dominance is primarily driven by the region’s well-established healthcare infrastructure, elevated healthcare expenditure, and the presence of major pharmaceutical and nutraceutical manufacturers.
The market’s expansion is further supported by rising consumer demand for dietary supplements and growing adoption of preventive healthcare practices. Moreover, strict regulatory frameworks in the region ensure product quality and safety, reinforcing North America’s strong market position.
Emerging Trends
- Adoption of Plant-Based Capsules: There is a growing shift from gelatin-based capsules to plant-derived alternatives like hydroxypropyl methylcellulose (HPMC) and pullulan. This transition caters to vegetarians, vegans, and individuals with dietary restrictions. Pullulan, a polysaccharide produced by the fungus Aureobasidium pullulans, offers benefits such as biodegradability and non-toxicity, making it suitable for capsule production.
- Advancements in Capsule Technology: Innovations include the development of enteric-coated capsules that resist stomach acid, ensuring targeted release in the intestines. Such advancements enhance drug efficacy and patient compliance.
- Integration in Inhalation Therapies: Empty capsules are increasingly used in dry powder inhalers (DPIs) for respiratory conditions like asthma and COPD. Capsules made from gelatin or HPMC are filled with medication powders, providing accurate dosing and improved drug delivery to the lungs.
Use Cases
Pharmaceutical Applications
- Medication Delivery: Capsules are employed to encapsulate a variety of drugs, including antibiotics and anti-inflammatory agents, facilitating controlled release and masking unpleasant tastes.
- Enhanced Solubility: Techniques like hot-melt extrusion are used to improve the solubility of poorly water-soluble drugs when encapsulated, leading to better bioavailability.
Dietary Supplements
- Nutrient Encapsulation: Vitamins, minerals, and herbal extracts are commonly delivered in capsule form, offering precise dosing and protection from environmental factors.
- Regulatory Compliance: The FDA mandates that dietary supplements be labeled appropriately, and capsules provide a standardized method for compliance.
Diagnostic Tools
- Innovative use of capsules includes their role in minimally invasive diagnostic devices. For instance, nanofiber capsules can collect biological samples from the gastrointestinal tract, aiding in early disease detection.
Conclusion
In conclusion, the global empty capsules market is experiencing steady growth, driven by increasing demand from pharmaceutical and nutraceutical industries, a shift toward plant-based formulations, and advancements in drug delivery technologies. Non-gelatin capsules are gaining preference due to clean-label trends, dietary considerations, and enhanced stability.
North America maintains market leadership, while Asia-Pacific is set for rapid expansion. Technological innovations—such as enteric coatings and inhalation therapies are broadening application areas. With evolving consumer preferences and stringent regulatory environments, the market presents promising opportunities for innovation, sustainability, and targeted drug delivery across diverse healthcare and wellness segments.
Discuss your needs with our analyst
Please share your requirements with more details so our analyst can check if they can solve your problem(s)
